PRF1 and renal cell carcinoma: ,22,23 RCC samples enriched for TAMs and MDSCs displayed compromised T cell functionality, characterized by elevated expression of immune checkpoint molecules such as PD-1 and reduced production of cytotoxic effectors, including Perforin and Granzyme B (Figures 1J and 1K).